Next-Generation Biologics Market Report

Global and China Next-Generation Biologics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 27, 2022
  • PAGES：185
  • REPORT CODE：GMM1414061
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Next-Generation Biologics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Allergan

    • Molecular Partners

    • Roche

    • Sanofi

    • Novo Nordisk

    • Eli Lilly

    • Pfizer

    • Bayer

    • Biogen Idec

    • Kyowa Hakko Kirin

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Antibodies

    • Regenerative medicine

    • Insulins

    • Growth hormones

    • Other

    Application:

    • Medical

    • Scientific Research

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Next-Generation Biologics Industry Overview

      • 1.1.1 Next-Generation Biologics Market Scope and Market Segments

      • 1.1.2 Next-Generation Biologics Industry Characteristics

      • 1.1.3 Global and China Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Next-Generation Biologics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Next-Generation Biologics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Antibodies

      • 1.2.2 Regenerative medicine

      • 1.2.3 Insulins

      • 1.2.4 Growth hormones

      • 1.2.5 Other

    • 1.3 Global Next-Generation Biologics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Medical

      • 1.3.2 Scientific Research

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Next-Generation Biologics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Next-Generation Biologics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Next-Generation Biologics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Next-Generation Biologics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Next-Generation Biologics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Next-Generation Biologics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Next-Generation Biologics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Next-Generation Biologics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Next-Generation Biologics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Next-Generation Biologics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Next-Generation Biologics Industry PEST Analysis

    • 2.3 Next-Generation Biologics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Next-Generation Biologics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Next-Generation Biologics Industry

    Chapter 3 Global and China Next-Generation Biologics Market, by Manufacturer

    • 3.1 Global and China Next-Generation Biologics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Next-Generation Biologics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Next-Generation Biologics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Next-Generation Biologics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Next-Generation Biologics Market Top 3 Players

    Chapter 4 Global and China Next-Generation Biologics Market, by Type (2017-2028)

    • 4.1 Next-Generation Biologics Market Trend, by Type

    • 4.2 Global Next-Generation Biologics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Next-Generation Biologics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Next-Generation Biologics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Next-Generation Biologics Price Trend, by Type (2017-2028)

    • 4.3 China Next-Generation Biologics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Next-Generation Biologics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Next-Generation Biologics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Next-Generation Biologics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Next-Generation Biologics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Next-Generation Biologics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Next-Generation Biologics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Next-Generation Biologics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Next-Generation Biologics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Next-Generation Biologics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Next-Generation Biologics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Next-Generation Biologics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Next-Generation Biologics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Next-Generation Biologics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Next-Generation Biologics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Next-Generation Biologics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Next-Generation Biologics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Next-Generation Biologics Market Analysis

    • 7.1 North America Next-Generation Biologics Market, by Type

    • 7.2 North America Next-Generation Biologics Market, by Application

    • 7.3 North America Next-Generation Biologics Market Analysis and Forecast, by Country

      • 7.3.1 United States Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Next-Generation Biologics Market Analysis

    • 8.1 Europe Next-Generation Biologics Market, by Type

    • 8.2 Europe Next-Generation Biologics Market, by Application

    • 8.3 Europe Next-Generation Biologics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Next-Generation Biologics Market Analysis

    • 9.1 APAC Next-Generation Biologics Market, by Type

    • 9.2 APAC Next-Generation Biologics Market, by Application

    • 9.3 APAC Next-Generation Biologics Market Analysis and Forecast, by Country

      • 9.3.1 China Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Next-Generation Biologics Market Analysis

    • 10.1 Latin America, Middle East and Africa Next-Generation Biologics Market, by Type

    • 10.2 Latin America, Middle East and Africa Next-Generation Biologics Market, by Application

    • 10.3 Latin America, Middle East and Africa Next-Generation Biologics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Next-Generation Biologics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Next-Generation Biologics Company Profiles

      • 11.1 Allergan

        • 11.1.1 Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Allergan Next-Generation Biologics Product Profiles, Application and Specification

        • 11.1.3 Allergan Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Molecular Partners

        • 11.2.1 Molecular Partners Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Molecular Partners Next-Generation Biologics Product Profiles, Application and Specification

        • 11.2.3 Molecular Partners Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Roche

        • 11.3.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Roche Next-Generation Biologics Product Profiles, Application and Specification

        • 11.3.3 Roche Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Sanofi

        • 11.4.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Sanofi Next-Generation Biologics Product Profiles, Application and Specification

        • 11.4.3 Sanofi Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Novo Nordisk

        • 11.5.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Novo Nordisk Next-Generation Biologics Product Profiles, Application and Specification

        • 11.5.3 Novo Nordisk Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Eli Lilly

        • 11.6.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Eli Lilly Next-Generation Biologics Product Profiles, Application and Specification

        • 11.6.3 Eli Lilly Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Pfizer

        • 11.7.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Pfizer Next-Generation Biologics Product Profiles, Application and Specification

        • 11.7.3 Pfizer Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Bayer

        • 11.8.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Bayer Next-Generation Biologics Product Profiles, Application and Specification

        • 11.8.3 Bayer Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Biogen Idec

        • 11.9.1 Biogen Idec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Biogen Idec Next-Generation Biologics Product Profiles, Application and Specification

        • 11.9.3 Biogen Idec Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Kyowa Hakko Kirin

        • 11.10.1 Kyowa Hakko Kirin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Kyowa Hakko Kirin Next-Generation Biologics Product Profiles, Application and Specification

        • 11.10.3 Kyowa Hakko Kirin Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Next-Generation Biologics Industry Investment Prospect and Risk Assessment

    • 12.1 Next-Generation Biologics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Next-Generation Biologics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure China Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Next-Generation Biologics Production Value and Growth Rate (2017-2028)

    • Figure China Next-Generation Biologics Production Value and Growth Rate (2017-2028)

    • Figure Global Next-Generation Biologics Market Size and Growth Rate of Antibodies (2017-2028)

    • Figure Global Next-Generation Biologics Market Size and Growth Rate of Regenerative medicine (2017-2028)

    • Figure Global Next-Generation Biologics Market Size and Growth Rate of Insulins (2017-2028)

    • Figure Global Next-Generation Biologics Market Size and Growth Rate of Growth hormones (2017-2028)

    • Figure Global Next-Generation Biologics Market Size and Growth Rate of Other (2017-2028)

    • Figure Global Next-Generation Biologics Market Size and Growth Rate of Medical (2017-2028)

    • Figure Global Next-Generation Biologics Market Size and Growth Rate of Scientific Research (2017-2028)

    • Figure Global Next-Generation Biologics Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Next-Generation Biologics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Next-Generation Biologics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Next-Generation Biologics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Next-Generation Biologics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Next-Generation Biologics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Next-Generation Biologics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Next-Generation Biologics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Next-Generation Biologics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Next-Generation Biologics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Next-Generation Biologics Market Share, by Manufacturer in 2021

    • Figure Global and China Next-Generation Biologics Market Share, by Manufacturer in 2022

    • Table Global Next-Generation Biologics Sales Volume, by Type (2017-2028)

    • Table Global Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Figure Global Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Table Global Next-Generation Biologics Sales Value, by Type (2017-2028)

    • Table Global Next-Generation Biologics Sales Value Share, by Type (2017-2028)

    • Figure Global Next-Generation Biologics Price Trend, by Type (2017-2028)

    • Table China Next-Generation Biologics Sales Volume, by Type (2017-2028)

    • Table China Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Figure China Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Table China Next-Generation Biologics Sales Value, by Type (2017-2028)

    • Table China Next-Generation Biologics Sales Value Share, by Type (2017-2028)

    • Figure China Next-Generation Biologics Price Trend, by Type (2017-2028)

    • Table Global Next-Generation Biologics Sales Volume, by Application (2017-2028)

    • Table Global Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Figure Global Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Table Global Next-Generation Biologics Sales Value, by Application (2017-2028)

    • Table Global Next-Generation Biologics Sales Value Share, by Application (2017-2028)

    • Figure Global Next-Generation Biologics Sales Value Share, by Application (2017-2028)

    • Table China Next-Generation Biologics Sales Volume, by Application (2017-2028)

    • Table China Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Figure China Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Table China Next-Generation Biologics Sales Value, by Application (2017-2028)

    • Table China Next-Generation Biologics Sales Value Share, by Application (2017-2028)

    • Figure China Next-Generation Biologics Sales Value Share, by Application (2017-2028)

    • Figure China Next-Generation Biologics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Next-Generation Biologics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Next-Generation Biologics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Next-Generation Biologics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Next-Generation Biologics Production, Import, Consumption and Export (2017-2022)

    • Table North America Next-Generation Biologics Sales Volume, by Type (2017-2028)

    • Table North America Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Figure North America Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Table North America Next-Generation Biologics Sales Volume, by Application (2017-2028)

    • Table North America Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Figure North America Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Figure United States Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Table Europe Next-Generation Biologics Sales Volume, by Type (2017-2028)

    • Table Europe Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Table Europe Next-Generation Biologics Sales Volume, by Application (2017-2028)

    • Table Europe Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure UK Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure France Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure France Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Table APAC Next-Generation Biologics Sales Volume, by Type (2017-2028)

    • Table APAC Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Table APAC Next-Generation Biologics Sales Volume, by Application (2017-2028)

    • Table APAC Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Figure China Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure China Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure India Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure India Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Next-Generation Biologics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Next-Generation Biologics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Next-Generation Biologics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Next-Generation Biologics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Next-Generation Biologics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Next-Generation Biologics Sales Value and Growth Rate (2017-2028)

    • Table Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Allergan Product Profiles, Application and Specification

    • Table Allergan Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Molecular Partners Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Molecular Partners Product Profiles, Application and Specification

    • Table Molecular Partners Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novo Nordisk Product Profiles, Application and Specification

    • Table Novo Nordisk Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biogen Idec Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biogen Idec Product Profiles, Application and Specification

    • Table Biogen Idec Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kyowa Hakko Kirin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kyowa Hakko Kirin Product Profiles, Application and Specification

    • Table Kyowa Hakko Kirin Next-Generation Biologics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US